[HTML][HTML] Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation

…, L Olmer, Y Shemer-Avni, T Wolf, L Supino-Rosin… - …, 2020 - thelancet.com
Background An Israeli national taskforce performed a multi-center clinical and analytical
validation of seven serology assays to determine their utility and limitations for SARS-CoV-2 …

Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination

…, V Nadler, T Wolf, R Lazar, L Supino-Rosin… - Vaccine, 2021 - Elsevier
Deployment of the BNT162b2 mRNA Covid-19 Vaccine in Israel began in December 2020.
This is a retrospective analysis of serological data, showing SARS-CoV-2 anti-S IgG kinetics …

[HTML][HTML] Effectiveness of mRNA BNT162b2 vaccine 6 months after vaccination among patients in large health maintenance organization, Israel

…, SB Gez, Y Saciuk, L Supino-Rosin… - Emerging infectious …, 2022 - ncbi.nlm.nih.gov
Israel experienced a new wave of coronavirus disease during June 2021, six months after
implementing a national vaccination campaign. We conducted 3 discrete analyses using data …

Increased incidence of coeliac disease autoimmunity rate in Israel: a 9‐year analysis of population‐based data

…, G Chodick, R Kariv, L SupinoRosin… - Alimentary …, 2021 - Wiley Online Library
Background Incidence rate and temporal trends in coeliac disease and coeliac disease
autoimmunity incidence vary worldwide with most data available from North American and …

Robust antibody response after a third BNT162b2 vaccine compared to the second among immunocompromised and healthy individuals, a prospective longitudinal …

…, B Mizrahi, D Rahamim-Cohen, L Supino-Rosin… - Vaccine, 2022 - Elsevier
Purpose As protection from COVID-19 following two doses of the BNT162b2 vaccine showed
a time dependent waning, a third (booster) dose was administrated. This study aims to …

[HTML][HTML] SARS-CoV-2 spike IgG titres up to 137 days following Comirnaty mRNA COVID-19 vaccination, Israel, February to May 2021

…, L Schreiber, R Lazar, L Supino-Rosin… - …, 2022 - eurosurveillance.org
Background Data regarding the long-term protection afforded by vaccination for the SARS-CoV-2
infection are essential for allocation of scarce vaccination resources worldwide. …

[HTML][HTML] Intracellular retention and degradation of the epidermal growth factor receptor, two distinct processes mediated by benzoquinone ansamycins

L Supino-Rosin, A Yoshimura, Y Yarden… - Journal of Biological …, 2000 - ASBMB
Epidermal growth factor (EGF) stimulates the growth of various types of cells via its cell
surface tyrosine kinase receptor. The EGF receptor (EGF-R) has an oncogenic potential when …

Regulation of calpain and calpastatin in differentiating myoblasts: mRNA levels, protein synthesis and stability

S BARNOY, L SUPINO-ROSIN… - Biochemical …, 2000 - portlandpress.com
Calpain (Ca 2+ -dependent intracellular protease)-induced proteolysis has been considered
to play a role in myoblast fusion to myotubes. We found previously that calpastatin (the …

A cytosolic domain of the erythropoietin receptor contributes to endoplasmic reticulum‐associated degradation

L SupinoRosin, A Yoshimura… - European journal of …, 1999 - Wiley Online Library
The erythropoietin receptor (EPO‐R) is the cellular target for erythropoietin (EPO), the primary
hormone that mediates the proliferation of immature erythroblasts and their differentiation …

[HTML][HTML] Identification of a cytoplasmic motif in the erythropoietin receptor required for receptor internalization

I Levin, J Cohen, L Supino-Rosin, A Yoshimura… - FEBS letters, 1998 - Elsevier
Erythropoietin (EPO) promotes the viability, proliferation and differentiation of mammalian
erythroid progenitor cells via its specific cell surface receptor. The EPO receptor (EPO-R) is a …